Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Katherine W Ferrara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-4976-9107; OpenAlex author ID A5013037422; NIH RePORTER profile ID 1872588. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
4
Labs led
2
Collaborators
8
Papers, trials and grants by year

2020: 1 paper, 1 grant · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper, 1 grant · 2025: 1 grant · 2026: 1 grant

Papers 3

  1. Spatial transcriptomic analysis drives PET imaging of tight junction protein expression in pancreatic cancer theranostics. Last author DOI 10.1038/s41467-024-54761-6↗
  2. Multiomic analysis for optimization of combined focal and immunotherapy protocols in murine pancreatic cancer. Last author DOI 10.7150/thno.73218↗
  3. Gemcitabine-retinoid prodrug loaded nanoparticles display in vitro antitumor efficacy towards drug-resilient human PANC-1 pancreatic cancer cells. Last author DOI 10.1016/j.msec.2020.111251↗

Grants 4

  1. Development of a theragnostic radiopharmaceutical for pancreatic cancer R01CA289924↗
  2. Imaging Modulation of Immune Phenotype R01CA250557↗
  3. HIFU-immunotherapy in pancreatic cancer R01CA253316↗
  4. Image-guided ultrasound therapy and drug delivery in pancreatic cancer R01CA210553↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ronald Levy · 1 shared grant, 2025 · strength 1.07
  2. James Wang · 2 shared papers, 2022–2024 · strength 0.30
  3. Sofia Ferreira · 1 shared paper, 2024 · strength 0.16
  4. Andrei Iagaru · 1 shared paper, 2024 · strength 0.16
  5. Walter Gwang-Up Park · 1 shared paper, 2024 · strength 0.16
  6. Laura D Attardi · 1 shared paper, 2024 · strength 0.16
  7. Hamilton Kakwere · 1 shared paper, 2020 · strength 0.16
  8. Daniel A. King · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.